Drug Profile
Research programme: obesity therapeutics - Takeda/Florida Hospital/Sanford-Burnham Medical Research Institute
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Florida Hospital; Sanford-Burnham Medical Research Institute; Takeda
- Developer Florida Hospital; Sanford Burnham Prebys Medical Discovery Institute; Takeda
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Obesity in Japan
- 16 Jul 2016 No recent reports of development identified for research development in Obesity in USA
- 27 Dec 2010 Early research in Obesity in Japan (unspecified route)